자기 자본과 준비금 변화 날짜
AbbVie USD -4.58B 1.35B 2026-09
Agenus USD -199.08M 22.15M 2026-06
Agios Pharmaceuticals USD 979.34M 46.68M 2026-09
Alnylam Pharmaceuticals USD 3.6B 2.25B 2026-09
Amgen USD 14.35B 2.66B 2026-09
Astellas Pharma JPY 1.98T 39.03B 2026-09
AstraZeneca USD 51.73B 1.43B 2026-09
Biogen USD 19.04B 194.3M 2026-09
BioMarin Pharmaceutical USD 6.26B 65.66M 2026-09
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Eli Lilly USD 40.27B 6.39B 2026-09
Gilead Sciences USD 13.04B 1.3B 2026-09
GlaxoSmithKline GBP 18.75B 1.11B 2026-09
Incyte USD 5.64B 701.49M 2026-09
Ionis Pharmaceuticals USD 439.74M 51.68M 2026-06
J&J USD 81.53B 3.44B 2026-09
Kyowa Hakko Kirin JPY 908.54B 7.62B 2026-09
Merck USD 44.89B 2.96B 2026-09
Moderna USD 6.76B 647M 2026-06
Neurocrine Biosciences USD 3.88B 185.1M 2026-09
Novartis USD 37.23B 4.72B 2026-09
Novartis USD 37.56B 1.36B 2026-09
Pfizer USD 89B 3.81B 2026-09
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Roche Holding CHF 32.69B 1.11B 2026-06
Sanofi EUR 69.57B 3.58B 2026-06
Sarepta Therapeutics USD 1.53B 22.7M 2026-06
Teva Pharmaceutical Industries USD 7.98B 226M 2026-09
Ultragenyx Pharmaceutical USD -376M 85M 2026-09
United Therapeutics USD 6.28B 124.3M 2026-09
Vertex Pharmaceuticals USD 20.91B 659.5M 2026-09